Kidney failure without treatment typically leads to death within days to months, depending on how suddenly the kidneys stop working and whether any residual function remains. Systematic reviews of patients who forgo dialysis report median survival ranging from about one month to as long as 41 months, with most cohorts clustering around six months to two years. When someone already on dialysis stops treatment, the timeline compresses sharply: most die within about a week. These numbers vary enormously based on age, remaining kidney function, and the presence of other serious illnesses, so the honest answer is a range, not a single number.
When Someone Chooses Not to Start Dialysis
For people with advanced chronic kidney disease who decide against dialysis, a path sometimes called conservative kidney management, survival depends heavily on how much kidney function is left at that decision point. A systematic review in the Journal of Palliative Medicine found that conservative management resulted in a median survival of at least six months, with individual study medians ranging from about 6 to 23 months.1PubMed Central. Conservative Management of End-Stage Renal Disease without Dialysis: A Systematic Review A more recent systematic review in JAMA Network Open, which looked at cohorts with average kidney filtration rates between 7 and 19 mL/min, found an even wider spread: median survival across studies ranged from 1 to 41 months.2JAMA Network Open. Long-term Outcomes Among Patients With Advanced Kidney Disease Who Forgo Maintenance Dialysis: A Systematic Review
That enormous range reflects real differences between patients. Someone in their sixties with a filtration rate around 15 mL/min and no diabetes may live two or three years without dialysis. Someone in their eighties with heart failure and a filtration rate in single digits may have only weeks. The decision point itself also varies: some studies measured from when the patient chose conservative care, others from when their kidneys crossed a specific threshold, and that methodological difference alone can shift the median by many months.
After Stopping Dialysis
People who have been on dialysis and then discontinue it face a much shorter timeline. A study of 126 patients who stopped dialysis found that the average survival from the last treatment was about 8 days, with half dying within 6 days.3JAMA Internal Medicine. Dying Well After Discontinuing the Life-Support Treatment of Dialysis An earlier study found a similar average of roughly 10 days.4PubMed. Dialysis discontinuation. A ‘good’ death? Outliers do exist: a handful of patients in the larger study survived 30 to 46 days after their last session, likely because they still produced some urine on their own.3JAMA Internal Medicine. Dying Well After Discontinuing the Life-Support Treatment of Dialysis
The reason the window is so short is that dialysis-dependent patients have little to no residual kidney function. Once the machine stops clearing waste and fluid, toxins accumulate fast. Most people become increasingly drowsy, slip into unconsciousness, and die peacefully within a week. Palliative care teams often describe this as one of the more predictable end-of-life trajectories in medicine, which helps families prepare.
What Actually Kills You When Kidneys Fail
Kidney failure doesn’t kill in a single way. Several overlapping mechanisms can become fatal, and which one dominates depends on how quickly the failure develops and what other organs are involved.
- High potassium: Failing kidneys cannot clear potassium from the blood. As levels rise, potassium disrupts the electrical signals that control the heartbeat. Modest elevations can speed the heart, but as levels climb further, the heart’s conduction system slows dramatically and can stop altogether. On an ECG, clinicians watch for tall, peaked T-waves and widening QRS complexes as warning signs that cardiac arrest is approaching.5Nephrology Dialysis Transplantation. Hyperkalemia: pathophysiology, risk factors and consequences
- Fluid overload: Without functioning kidneys, the body retains salt and water. Fluid backs up into the lungs, producing pulmonary edema, which makes breathing progressively harder and can become fatal if not treated.6PubMed Central. Detecting and Treating Lung Congestion with Kidney Failure
- Uremic toxicity: Waste products that the kidneys normally excrete build up and poison the brain and other organs. This starts as confusion and drowsiness, progresses to seizures, and can end in coma.
- Metabolic acidosis: The kidneys help regulate the body’s acid-base balance. When they fail, acid accumulates in the blood. In people with chronic kidney disease, sustained acidosis has been linked to roughly 40 percent higher all-cause mortality compared to those with normal acid levels.7PubMed Central. Metabolic Acidosis in Chronic Kidney Disease: Pathogenesis, Clinical Consequences, and Treatment
- Infection: Kidney failure weakens the immune system. In large cardiovascular outcomes trials, infections accounted for roughly a quarter to a third of all deaths in patients with advanced kidney disease, rivaling cardiovascular causes.8European Heart Journal. Causes of death in patients with chronic kidney disease: insights from the ASCEND-D and ASCEND-ND cardiovascular outcomes trials
In practice, cardiovascular disease is the leading killer once kidney filtration drops below about 60 mL/min. A large study of over 81,000 deaths found that as kidney function declined, the proportion of cardiovascular deaths rose steadily, reaching nearly 44 percent in those with the most severely reduced function, while cancer deaths became proportionally less common.9PubMed Central. Cause of Death in Patients with Reduced Kidney Function Heart failure and sudden cardiac arrest dominate the cause-of-death statistics for people who reach end-stage disease.
What Determines How Long Someone Survives
The range of survival times in kidney failure is so wide that averages can be misleading. Several factors matter far more than the kidney disease itself.
Residual urine output is one of the strongest predictors. Among people already on hemodialysis, those who still produced some urine on their own had substantially better survival than those who did not. The mortality risk for patients with no residual urine output was roughly 80 percent higher after adjusting for other factors.10Kidney International Reports. Residual Urine Output and Mortality in a Prospective Hemodialysis Cohort Even a small amount of remaining kidney function helps clear toxins and fluid between dialysis sessions, and its loss marks a shift toward greater dependence on the machine.
Whether the kidneys fail slowly or suddenly also matters. Acute kidney injury that strikes on top of existing chronic kidney disease is particularly dangerous. In one study, about a quarter of chronic kidney disease patients who developed a sudden, superimposed kidney injury died during that hospitalization. Survivors who already had moderate-to-severe chronic disease faced a high chance of progressing to end-stage disease within 30 days of discharge.11PubMed Central. Nonrecovery of kidney function and death after acute on chronic renal failure Slow, predictable decline gives the body time to adapt; a sudden crash does not.
Whether urine output drops to very low levels also carries prognostic weight. In intensive-care patients with acute kidney injury, those who became oliguric (producing very little urine) had about 50 percent higher odds of dying in the hospital compared to those who maintained higher urine volumes.12PubMed Central. Short- and long-term outcomes in oliguric and non-oliguric acute kidney injury in intensive care
Comorbidities, particularly cardiovascular ones, often matter more than age alone. A study of kidney transplant recipients over 65 found that age by itself was not significantly associated with death, but having three cardiovascular comorbidities carried a roughly 3.6-fold higher mortality risk compared to having none.13Nephrology Dialysis Transplantation. #2288 Survival and care trajectory of kidney graft patients after age 65 Diabetes, heart failure, and peripheral vascular disease compress the survival timeline far more than calendar age does.
Does Dialysis Always Help You Live Longer
For most people with end-stage kidney disease, dialysis extends life, often substantially. A meta-analysis of 12 studies found that patients who chose dialysis had roughly half the mortality risk of those managed conservatively, after adjusting for other differences.14PubMed Central. Survival of patients who opt for dialysis versus conservative care: a systematic review and meta-analysis That is a large benefit, and for younger patients or those with fewer comorbidities, dialysis can add years of life.
The picture gets murkier for very elderly or very frail patients. One study comparing hemodialysis and conservative care in elderly patients found that while dialysis offered a clear early survival advantage, that benefit did not persist beyond the first two months for those who survived the initial period. For a 65-year-old, the point at which the two groups’ mortality risks equalized was about two to three months; for a 95-year-old, it was about one month.15PLoS ONE. Survival analysis of conservative vs. dialysis treatment of elderly patients with CKD stage 5 That does not mean dialysis is useless for elderly patients; it means the benefit narrows in people who are very old or very sick.
Other research paints a more favorable picture of dialysis even at advanced ages. A propensity-score analysis found that even among patients aged 80 and older, those who chose hemodialysis had significantly better survival than those managed conservatively.16PubMed Central. Survival rates in comprehensive conservative care compared to dialysis therapy in elderly end-stage kidney disease patients: a propensity score analysis The disagreement in the literature reflects how hard it is to study this question cleanly: patients who choose conservative care tend to be sicker and frailer than those who start dialysis, and no amount of statistical adjustment fully corrects for that.
A narrative review in Kidney Medicine noted that there is growing evidence that the very oldest patients, those aged 80 and above with high comorbidity and poor functional status, may no longer see a clear survival advantage from dialysis.17PubMed Central. Survival of Older Patients With Advanced CKD Managed Without Dialysis: A Narrative Review Quality of life, travel to dialysis centers, and the physical toll of treatment all factor into a decision that becomes genuinely difficult when the survival benefit is small and uncertain.
Symptoms in the Final Weeks
For people managed without dialysis, the last month of life tends to be dominated by a heavy burden of symptoms. A study tracking patients in the final month before death found that the median number of symptoms reported was about 17, and more than half of patients experienced each of the following: profound lack of energy, itching, drowsiness, breathlessness, poor concentration, pain, loss of appetite, swelling in the arms or legs, dry mouth, constipation, and nausea.18Journal of Pain and Symptom Management. Symptoms in the Month Before Death for Stage 5 Chronic Kidney Disease Patients Managed Without Dialysis
These symptoms are not inevitable in their severity. Good palliative care can reduce pain, manage nausea, ease breathlessness with low-dose medications, and address the psychological distress that accompanies the final stages. Palliative and end-of-life care teams working with kidney patients have been shown to improve the experience for both patients withdrawing from dialysis and those who chose not to start it.19PubMed Central. Palliative and end-of-life care in advanced renal failure Drowsiness tends to increase as uremic toxins build, and many patients gradually become less aware of their symptoms in the final days. Families often report that the dying process itself, while distressing to witness, appears less uncomfortable than the preceding weeks.
The Decision to Stop or Not Start Dialysis
Stopping dialysis is one of the most common ways that people with end-stage kidney disease die. The decision is not straightforward, and the ethical landscape around it is well-established: patients have the right to refuse or discontinue any medical treatment, including dialysis. Shared decision-making between the patient, family, and medical team is the standard approach, balancing the patient’s values and quality of life against the potential survival benefit of continuing treatment.20PubMed Central. Withdrawal from Dialysis: Why and When?
Common reasons patients give for stopping include unacceptable quality of life, loss of independence, the physical burden of treatment, and the feeling that they have lived long enough. Depression and cognitive decline can complicate the decision, which is why most guidelines emphasize that psychiatric evaluation should be part of the process. A patient who is depressed may see their situation as more hopeless than it is, and treating the depression can sometimes change the decision entirely. But many patients make the choice with clear minds, and their autonomy deserves respect.
For families, this period is intense. A systematic review of caregivers of patients receiving conservative kidney management found that they experienced significant burden and quality-of-life impacts comparable to those caring for patients on dialysis.21PubMed Central. Experiences of Caregivers of Patients With Conservatively Managed Kidney Failure: A Mixed Methods Systematic Review Uncertainty about the future and the difficulty of negotiating deterioration emerged as major themes. Caregivers frequently said they needed better support, clearer information about what to expect, and more involvement in decisions about the care plan.
When There Is No Access to Treatment at All
Everything discussed so far assumes that dialysis or transplant is available and the question is whether to use it. In much of the world, that assumption does not hold. Roughly 96 percent of patients with kidney failure in low-income countries who would need kidney replacement therapy do not have access to it, and the figure is about 90 percent in lower-middle-income countries.22Seminars in Nephrology. The Impact of Low Socioeconomic Status on Progression of Chronic Kidney Disease in Low- and Lower Middle-Income Countries For these patients, kidney failure is a death sentence by default, often within weeks to months, without the cushion of a managed choice between dialysis and conservative care.
Even within wealthier countries, access is uneven. People without insurance, those in rural areas far from dialysis centers, and undocumented immigrants face barriers that can delay or prevent treatment. The global picture of kidney failure mortality is shaped as much by geography and economics as by biology. The survival ranges quoted earlier in this article come overwhelmingly from high-income countries where treatment is available, and they cannot be generalized to populations where it is not.